IMPACTfolio’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
IMPACTfolio's ABBV Position: Q2 2026 in Review
IMPACTfolio held its AbbVie (ABBV) position steady in Q2 2026 at 1,761 shares worth $443K. The position accounts for 0.17% of the portfolio, ranked #23.
IMPACTfolio first reported a position in ABBV in Q4 2022 and has held it in 13 quarters since. The position peaked at $488K in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- IMPACTfolio held 1,761 shares of AbbVie worth $443K as of Q2 2026.
- IMPACTfolio left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.17% of IMPACTfolio's portfolio in Q2 2026, its #23 holding.
- IMPACTfolio first reported a position in AbbVie in Q4 2022 and has held it in 13 quarters since.
- IMPACTfolio's AbbVie position peaked at $488K in Q3 2025.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on IMPACTfolio's 13F filing for Q2 2026, filed 22 Jul 2026.